Becker's Healthcare August 2, 2024
Elizabeth Gregerson

The FDA has approved the gene therapy Tecelra for treatment of synovial sarcoma.

Tecelra, developed by biopharmaceutical company Adaptimmune, is the first gene therapy treatment for adult patients with unresectable or metastatic synovial sarcoma to be approved by the FDA, according to an Aug. 2 news release from the agency.

Synovial sarcoma...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
Marty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDA
Gutting FDA Won't Make America Healthy
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency

Share This Article